Advanced Therapies Journal

Advanced Therapies Journal

Advanced Therapies Journal was first published in 2018 as pharmacogenomics and Omics technologies  Journal and in 2023 reviewed for optimization and reformed to advanced therapies journal. Now ATJ is a premium home for the publication of interdisciplinary research on the next-generation of therapeutics and advanced therapies. The articles selected for the Editors' Choice are representative of the key topics that the journal publishes, including targeted drug delivery; drug discovery; cellular, genetic, and immunotherapies; personalized and precision medicines; theranostics; omics technologies, tissue engineering, pharmacology; toxicology, and highlight work done by researchers from across the globe.

Publication Information

Publisher

Editor-in-Chief
Director-in-Charge
Executive Manager

Frequency
Quarterly
Print ISSN
Online ISSN

Indexing and Abstracting

Keywords Cloud

  • Personalized Medicine
  • Artificial intelligence
  • Machine Learning
  • precision medicine
  • Immunotherapy
  • breast cancer
  • Genomic analysis
  • Biomarkers
  • Autoimmune disorders
  • Systemic lupus erythematosus
  • Immune checkpoint inhibitors
  • systemic lupus erythematosus (SLE)
  • Synthetic biology
  • Gut microbiota
  • cancer immunotherapy
  • Multiple Sclerosis
  • Pharmacogenomics
  • Genomics
  • Rheumatoid arthritis
  • Drug resistance
  • Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
  • Gene Therapy
  • Multi-omics integration
  • COVID-19
  • CAR-T cell therapy toxicities
  • Monoclonal antibodies
  • Nanocarriers
  • cancer vaccine
  • Nanotechnology
  • Nanoparticles
  • Advanced Therapies
  • Cancer treatment
  • nanomedicine
  • Cancer therapy
  • cancer
  • Cytokine Release Syndrome (CRS)
  • Tumor Microenvironment
  • probiotics
  • Drug targeting
  • Aromatase Inhibitors (AIs)
  • , Adoptive Cell Therapy, Genetic Engineering
  • medicinal plants
  • Combination therapy
  • immune modulation
  • Antibiotic resistance pediatric populations
  • phage display
  • individualized therapy
  • Vaccine development
  • Cancer Genomics
  • Precision tumor drug delivery
  • Cytokines
  • pharmacokinetics
  • Controlled drug delivery
  • tyrosine kinase inhibitors
  • Personalized therapies
  • Severity of disease
  • Metastasis
  • solid tumors
  • Antimicrobial
  • Live materials
  • Genetic engineering
  • Lactococcus lactis
  • wound dressing
  • mRNA Vaccines
  • NSCLC
  • Hydrogel
  • viral vector vaccines
  • Light-activated therapy
  • hydrogels
  • Cyclin-Dependent Kinase Inhibitors (CDK)
  • Traditional vaccines
  • Adoptive-cell therapy
  • Drug Development
  • Sickle cell disease
  • Biomaterials
  • burn management
  • COVID-19 meta-analysis
  • Pharmacogenomics, Precision Medicine
  • Phenylalanine ammonia-lyase
  • Health behavior
  • Age-Related Diseases
  • PD-1
  • Precision nanomedicine
  • Autoimmune Diseases
  • Neuroplasticity, Immunomodulation
  • Neurodegenerative Diseases
  • breast malignancies
  • Antiviral therapy
  • Air pollution
  • immune system
  • Smart targeted nanoparticles
  • CD40-CD40L pathway
  • geriatric healthcare
  • Oncolytic Viruses
  • Precision Diagnostics
  • colorectal cancer
  • lupus nephritis
  • Antifungal therapy
  • Tumor lysis
  • Neurofilament Light Chain
  • risk factors
  • RET fusion
  • Pharmacological therapy
  • Urinary exosomes
  • Particulate Matter
  • Personalized therapy
  • Bacteriophage
  • Cellular Functions
  • Next-Generation Sequencing (NGS)
  • Precision Neurology
  • reactive oxygen species
  • CD154/CD40
  • Cancer management
  • Natural Antimicrobials
  • KRAS signaling
  • RET alterations
  • Personalized medicine. Neutrophil
  • Inflammation
  • Host Genetic Variations, Respiratory Viral Infections, Disease Severity
  • PBSC Manifestation
  • Lung cancer
  • cell therapy
  • Chimeric antigen receptor
  • Chronic wounds
  • Solid Tumor
  • metabolomic signatures, Targeted therapy, Omics technologies
  • Antibiotic Resistance
  • Biomarker-guided
  • Psoriasis
  • age
  • Vaccinia virus
  • Diabetic foot ulcers
  • Regenerative medicine
  • DNA vaccine
  • therapy
  • infection prevention
  • Selective Estrogen Receptors Modulator (SERM)
  • Photodynamic therapy
  • targeted cancer therapy
  • Genomic data
  • Diabetes Mellitus
  • live biotherapeutic products
  • Precision oncology
  • Antimicrobial Resistance
  • tumor vaccine
  • Alzheimer’s disease
  • Axonal regeneration
  • targeted therapy
  • Multidisciplinary pain management
  • Drug Delivery
  • targeted drug delivery
  • Phenylketonuria
  • Radiation therapy
  • smoking
  • Tissue engineering
  • psoriatic arthritis
  • personalized treatments
  • Elderly Care
  • Engineered Regulatory T cells, CAR-Tregs
  • gout
  • Antibody-Drug Conjugates
  • cytokine
  • Prostate Cancer
  • Non-pharmacological therapy
  • CRISPR/Cas9
  • Personalized Healthcare
  • CTLA-4
  • PD-L1
  • Drug delivery system
  • Autoimmune Disease
  • bioactive scaffolds
  • Neural stem cells, CNS regeneration
  • Active targeting
  • TKI
  • Viral Vector
  • plasmid engineering
  • β-thalassemia
  • Brachytherapy
  • Synthetic vaccines
  • non-invasive
  • neuroinflammation
  • Chronic pain
  • Cancer progression
  • Autoimmune Diseases, Immune Tolerance
  • Comprehensive analysis
  • Antibiotic delivery
  • Resistance Patterns
  • Body\'s response
  • immunological systems
  • Acute pain
  • Metabolic Syndrome